People with Fanconi anemia (FA) have a 500- to 700-fold increased risk of developing head and neck squamous cell carcinoma (HNSCC) tumors when compared to the general population. Conventional treatments available for non-FA-HNSCC such as radiation therapy and chemotherapy are...
Announcements
FARF t-shirts through the years Overview: To celebrate FARF’s 30th anniversary, we are asking our community to help design an original, limited edition FARF t-shirt. The winning design will earn you a scholarship to attend the FARF Symposium in downtown Chicago in September...
Announcements
One of FARF’s guiding principles is to gather the best researchers and clinicians in the FA community every year to share updates in research and care. In late 2018, we held the 30th Fanconi Anemia Scientific Symposium in Newport Beach,...
Announcements
When FARF created guiding principles back in 1989, one was that each year, we would bring together researchers working on FA and physicians treating people with FA. They would spend three days sharing updates and concerns, brainstorming ideas and creating collaborations. In...
Announcements
The holidays are a time to show gratitude and to give back. If you’re looking for a way to do both, consider joining the holiday campaign for FA research. Not only will you be helping those you know and love...
Announcements
https://www.youtube.com/watch?v=SFniw98z-n4 Dr. Agata Smogorzewska talks about her FA research project What motivates me to work on Fanconi anemia: I became interested in Fanconi anemia due to the critical function of FA proteins in DNA repair. Quite accidentally, I discovered a...
Announcements
